These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9853336)
1. 99Tcm-labelled chimeric human/mouse anti-granulocyte antibody bone marrow scintigraphy: a preliminary clinical study. Higuchi T; Inoue T; Sarwar M; Oriuchi N; Karasawa M; Naruse T; Yamanaka H; Watanabe T; Chung JK; Endo K Nucl Med Commun; 1998 May; 19(5):463-74. PubMed ID: 9853336 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer. Lacić M; Bokulić T; Lukac J; Kovacić K; Baum RP; Kusić Z Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162 [TBL] [Abstract][Full Text] [Related]
3. Detection of metastatic bone lesions in patients with prostate carcinoma: 99Tcm-monoclonal antibody imaging. Kiraç S; Duman Y; Cüreklibatur I; Yüksel D; Nazli O; Günaydin G; Taner M Nucl Med Commun; 1997 Oct; 18(10):968-73. PubMed ID: 9392800 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in bone marrow scanning. Reske SN Eur J Nucl Med; 1991; 18(3):203-21. PubMed ID: 2040342 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders. Chung JK; Yeo J; Lee DS; Park S; Lee MC; Kim BK; Koh CS J Nucl Med; 1996 Jun; 37(6):978-82. PubMed ID: 8683326 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibody. Ivancevic V; Huic D; Wolter A; Munz DL Nucl Med Commun; 2002 Mar; 23(3):249-55. PubMed ID: 11891483 [TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of the bone marrow imaging agent 99Tcm-phytate in the detection of bone metastases. Chang CP; Liu RS; Yu SM; Wynchank S; Chu LS; Shiau HY; Cheng TC Nucl Med Commun; 1996 Dec; 17(12):1030-4. PubMed ID: 9004298 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies. Zoeller G; Sandrock D; Munz DL; Ringert RH Eur Urol; 1994; 26(2):141-4. PubMed ID: 7957469 [TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy. Lee KH; Chung JK; Choi CW; Jeong JM; Lee DS; Bang YJ; Lee MC; Kim NK; Koh CS J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046 [TBL] [Abstract][Full Text] [Related]
11. 99Tcm-HMPAO-labelled leucocytes for bone marrow scintigraphy and evaluation of skeletal lesions. Comparison with 99Tcm-HSA colloid results. Bourgeois P; Demonceau G; Stegen M; Ferremans W Nucl Med Commun; 1991 Jul; 12(7):621-7. PubMed ID: 1923153 [TBL] [Abstract][Full Text] [Related]
12. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Reske SN; Karstens JH; Gloeckner W; Steinsträsser A; Schwarz A; Ammon J; Buell U Lancet; 1989 Feb; 1(8633):299-301. PubMed ID: 2563458 [TBL] [Abstract][Full Text] [Related]
13. Enhanced uptake of 99Tcm-MDP in skeletal metastases from prostate cancer following initiation of hormone treatment: potential for increasing delivery of therapeutic agents. Bushnell DL; Madsen M; Kahn D; Nathan M; Williams RD Nucl Med Commun; 1999 Oct; 20(10):875-81. PubMed ID: 10528290 [TBL] [Abstract][Full Text] [Related]
14. 99Tcm-LL1: a potential new bone marrow imaging agent. Juweid M; Dunn RM; Sharkey RM; Rubin AD; Hansen HJ; Goldenberg DM Nucl Med Commun; 1997 Feb; 18(2):142-8. PubMed ID: 9076770 [TBL] [Abstract][Full Text] [Related]
15. Scintigraphic evaluation of the haemopoietic bone marrow using a 99mTc-anti-granulocyte antibody: a validation study with 52Fe. Jamar F; Field C; Leners N; Ferrant A Br J Haematol; 1995 May; 90(1):22-30. PubMed ID: 7786791 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions. Sahin M; Basoglu T; Bernay I; Yapici O; Canbaz F; Yalin T Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma. Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796 [TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of skeletal scintigraphy and bone marrow scintigraphy in detection of osseous metastases]. Bathmann J; Moser E Radiologe; 1995 Jan; 35(1):8-14. PubMed ID: 7892445 [TBL] [Abstract][Full Text] [Related]
20. A comparison between 111In-anti-E-selectin mAb and 99Tcm-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis. Jamar F; Chapman PT; Manicourt DH; Glass DM; Haskard DO; Peters AM Br J Radiol; 1997 May; 70(833):473-81. PubMed ID: 9227228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]